TPST icon

Tempest Therapeutics
TPST

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $7.21M invested in Tempest Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

0.02% more ownership

Funds ownership: 2.24% → 2.27% (+0.02%)

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$39K
2
+$31.4K
3
+$25.7K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$20.8K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.75K

Top Sellers

1
-$13.1K
2
-$1.02K
3
-$151
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.39M
2
$1.91M
3
$1.5M
4
$580K
5
$301K
6
$193K
7
$155K
8
$61K
9
$39K
10
$31.4K
11
$25.7K
12
$20K
13
$1.15K
14
$1K
15
$232
16
$158
17
$21
18
–